ABSTRACT
BACKGROUND: This prospective trial examined the feasibility, toxicity, and effectiveness of early locoregional radiotherapy after high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk American Joint Committee on Cancer (AJCC) Stage II-III and locally advanced breast carcinoma. METHODS: One hundred forty-seven consecutive patients with high-risk and locally advanced breast carcinoma were included in the current study. All patients received induction chemotherapy with a doxorubicin-based therapy, which was consolidated with high-dose cyclophosphamide, carboplatin, and thiotepa followed by autologous stem cell support. Within 50 days of the transplant, the patients were treated with locoregional radiotherapy that included the chest wall or breast, the axilla and supraclavicular area, and the internal mammary chain. The volume of lung included in the treatment volume was kept to a minimum. The central lung distance of the tangential fields ranged from 0.6-2.0 cm (mean, 1.1 cm). Tamoxifen was given based on receptor status. RESULTS: One hundred forty-six of 147 patients received the planned treatment. Only six patients had a delay in the initiation of radiotherapy, and another 16 patients had delays during radiotherapy. Leukocyte and platelet toxicities during radiotherapy were not life-threatening and blood counts thereafter returned to normal. Grade 2 (according to National Cancer Institute Common Toxicity Criteria) skin toxicity occurred in 22% of patients and Grade 3 skin toxicity occurred in 6% of patients. Radiation pneumonitis was reported to occur in 5 patients (< 4%). After a median follow-up of 36 months from diagnosis (range, 6-64 months), there were no long-term organ toxicity and no secondary malignancy reported. No treatment-related deaths were reported. Three patients (< 3%) developed locoregional recurrence. CONCLUSIONS: Locoregional radiotherapy after high-dose chemotherapy and autologous stem cell transplantation appears to be feasible and can be delivered safely within 10 weeks of transplantation. The short-term and long-term toxicity are reported to be low, with good local control.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/radiotherapy , Carcinoma/drug therapy , Carcinoma/radiotherapy , Hematopoietic Stem Cell Transplantation , Adult , Aged , Carboplatin/administration & dosage , Cyclophosphamide/administration & dosage , Dose-Response Relationship, Drug , Doxorubicin/administration & dosage , Female , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Radiotherapy, Adjuvant/adverse effects , Thiotepa/administration & dosage , Treatment OutcomeSubject(s)
Naval Medicine , Psychophysiologic Disorders/therapy , Achievement , Age Factors , Bone Diseases/therapy , Follow-Up Studies , Gastrointestinal Diseases/therapy , Humans , Length of Stay , Male , Marriage , Muscular Diseases/therapy , Prognosis , Respiratory Tract Diseases/therapy , Time Factors , United States , Verbal Behavior , Wounds and Injuries/complicationsABSTRACT
The utilization of selected cognitive, demographic, and personal histroy measures as predictors of academic success for Naval Hospital Corps School personnel undergoing paramedical training was investigated using a smaple of 1,448 students. A composite criterion score reflecting grade-point average as well as administrative discharge was related to a number of preservice cognitive and noncognitive predictors. Multiple regression techniques were used to weight specific variables and to predict performance in a crossvalidation sample. Findings indicated that demographic and personal histroy measures contributed uniquely to prediction of academic success.
Subject(s)
Allied Health Personnel/education , Educational Measurement , Military Medicine , Age Factors , Demography , Educational Status , Marriage , Regression Analysis , United StatesSubject(s)
Naval Medicine , Substance-Related Disorders/epidemiology , Adolescent , Adult , Hallucinogens , Humans , Male , Psychological Tests , United StatesSubject(s)
Mental Disorders/epidemiology , Naval Medicine , Humans , Male , Socioeconomic Factors , United StatesABSTRACT
If viremic sera from mice chronically infected with lactic dehydrogenase virus (LDV) were first treated with ether or ultraviolet light to inactivate the infectious virus, neutralizing antibody could be demonstrated. Significant amounts of antibody, however, were not detected until the mice had been infected for about 2(1/2) months and its presence did not result in the elimination of the chronic viremia. Virus isolated from sera containing neutralizing antibody was found to be relatively resistant to neutralization by anti-LDV. Further studies revealed that the resistant virus existed in the form of an infectious virus-antibody complex (sensitized virus). The presence of such a complex was demonstrated by the fact that the virus fraction which persisted after in vivo or in vitro exposure to mouse anti-LDV was readily neutralized by goat anti-mouse sera or goat anti-mouse gamma-globulin, whereas virus that had not been previously exposed to mouse anti-LDV was completely resistant to neutralization by goat anti-mouse sera. These findings suggest that (a) sensitization may play an important role in the resistance and susceptibility of a virus to neutralization by antiviral antibody, and (b) an anti-gamma-globulin may prove useful in neutralizing the resistant fraction and in demonstrating otherwise undetectable antiviral antibody.